Sequence and expression of Tangier apoA-I gene

Area of Science:

• Genetics
• Molecular Biology
• Biochemistry

Background:

• Tangier disease is a rare genetic disorder affecting high-density lipoprotein (HDL) metabolism.
• Apolipoprotein A-I (apoA-I) is the major protein component of HDL and plays a crucial role in reverse cholesterol transport.

Purpose of the Study:

• To isolate and characterize the apoA-I gene from a Tangier disease patient.
• To determine if structural abnormalities or altered expression of the apoA-I gene contribute to Tangier disease.

Main Methods:

• Isolation of the apoA-I gene from a lambda L47.1 genomic library using DNA from Tangier disease patient lymphocytes.
• DNA sequencing to compare Tangier apoA-I protein sequence with normal apoA-I.
• Transfection of mouse C127 cells with a recombinant apoA-I gene vector.
• Analysis of apoA-I synthesis and secretion in transfected cells.

Main Results:

• The DNA-derived protein sequence of Tangier apoA-I was identical to normal apoA-I.
• Stable cell clones expressing the Tangier apoA-I gene were successfully generated.
• Secreted apoA-I from transfected cells was indistinguishable from that of control cells (HepG2).

Conclusions:

• The apoA-I gene in Tangier disease is structurally normal.
• The molecular basis of Tangier disease is unlikely to be due to apoA-I gene structure or its expression regulation.
• Other factors involved in apoA-I and HDL metabolism are likely responsible for Tangier disease pathogenesis.